Clinical Trial Update: Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409) [Phase 3]

View source ↗

Summary

Phase 3 safety study evaluating the combination of ciclesonide nasal spray with inhaled fluticasone propionate/salmeterol in adults with perennial allergic rhin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Hay Fever
• Perennial Allergic Rhinitis

Drugs mentioned

• Ciclesonide nasal spray (ciclesonide)
• Fluticasone propionate/salmeterol inhalation (fluticasone propionate / salmeterol)

Snippet

Sponsor: AstraZeneca | Conditions: Perennial Allergic Rhinitis, Allergic Rhinitis | Phase 3 | Status: COMPLETED